Cholangiocarcinoma

The Pharmacy Times® Cholangiocarcinoma Resource Center is a comprehensive resource for clinical news and expert insights on the treatment of cholangiocarcinoma.

Latest News

Laptop displaying FDA logo -- Image credit: monticellllo | stock.adobe.com
FDA Grants PLT012 Orphan Drug Designation for Liver, Intrahepatic Bile Duct Cancer

December 11th 2024

PLT012 demonstrates its potential against multiple tumors with unmet medical needs.

Biliary tract cancer -- Image credit: Thipphaphone | stock.adobe.com
Intravenous Injections of Zanidatamab-Hrii Receives FDA Accelerated Approval for IHC+ BTC

November 21st 2024

Pain related to bile duct cancer -- Image credit: vachiravit | stock.adobe.com
Tucatinib With Trastuzumab Shows Positive Effects in Patients With Bile Duct Cancer

October 29th 2024

3d illustration proteins with lymphocytes t cells or cancer cells | Image Credit: Design Cells - stock.adobe.com
Durvalumab With Chemotherapy Shows Long-Term Overall Survival at 3 Years

April 18th 2024

Medical conference panel
Pharmacists Can Help Address Treatment Challenges for Patients With Cholangiocarcinoma

December 19th 2023

Latest CME Events & Activities

The Impact of Pharmacists and Pharmacy Technicians in Recognizing and Responding to Human Trafficking (Pharmac...

2.0 Credits / Human Trafficking, Law

View More

Ensuring Pharmacy Technicians’ Proficiency in Risk Evaluation and Mitigation Strategies

1.0 Credit / Law, Pain Management, Opioids

View More

<12